Search for: "TORRENT PHARMACEUTICALS"
Results 41 - 60
of 72
Sort by Relevance
|
Sort by Date
20 Nov 2011, 5:20 am
Everyone makes money efficiently–except the people who create the stuff that’s being ripped off, whether its movies, music, high fashion or pharmaceuticals. [read post]
20 Nov 2011, 5:20 am
Everyone makes money efficiently–except the people who create the stuff that’s being ripped off, whether its movies, music, high fashion or pharmaceuticals. [read post]
2 Nov 2011, 2:00 am
General WIPO Re:Search bridges public, private sectors for neglected disease research (IP Watch) (WIPO) (IPKat) (IP Watch) (Patent Docs) WTO TRIPS Council: Ecuador questions the European Union on Italian compulsory licenses (KEI) KEI notes from the Ninth Round of TPPA negotiations (KEI) Brazil’s intervention at Special Session of the Executive Board on WHO Reform (KEI) WTO TRIPS Council: Canada’s intervention on Access to Medicines in context of Paragraph 6 and Bill C-393 (KEI)… [read post]
30 Oct 2011, 8:36 pm
• Defendants: Torrent Pharmaceuticals Ltd.; Torrent Pharma Inc. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]
7 Jul 2011, 2:31 pm
Novartis Pharmaceuticals Corp., ___ F. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
28 Nov 2010, 4:29 pm
In particular, torrent tracker sites have long confounded them. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
12 Sep 2010, 6:37 pm
It is not, as they emphasize, that all acts of trespass are good things, or that most of the college students on Bit Torrent have any ideal in mind more elevated than seeing movies for free. [read post]
31 Aug 2010, 10:01 pm
(Spicy IP) India: DIPP discussion paper on compulsory licensing in the Indian Pharmaceutical sector: An ‘acquired’ afterthought? [read post]
25 Aug 2010, 12:37 am
Torrent Pharmaceuticals Ltd. et al. [read post]
28 Jul 2010, 12:06 am
Torrent Pharmaceuticals Ltd. et al. [read post]
29 Jun 2010, 12:26 pm
This much is certain: Bilski opens the floodgates to new torrents of litigation over how abstract is too abstract. [read post]
9 Apr 2010, 8:30 am
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
24 Dec 2009, 11:32 am
AstraZeneca Pharmaceuticals, L.P., ___ S.W.3d ___, 2009 WL 3681868 (Ark. [read post]
24 Jul 2009, 10:00 am
Strong enough to avoid the waves of boom and bust that have time and time again unleashed a torrent of misfortune on middle-class families across the country. [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
12 Jul 2009, 9:21 pm
Torrent Pharmaceuticals Ltd. et... [read post]
22 Jan 2009, 11:57 pm
Torrent Pharmaceuticals Ltd. et alAhmedabad-based Torrent Pharmaceuticals Ltd. is accused of patent infringement by Wyeth for infringement of Orange Book listed US Patent Nos. 6,274,171 ("Extended release formulation of venlafaxine hydrochloride"), 6,403,120 ("Extended release formulation of venlafaxine hydrochloride"), and 6,419,958 ("Extended release formulation of venlafaxine hydrochloride") for anti-depressant drug Effexor XR… [read post]
